Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study

Abstract

BackgroundChronic conditions and multimorbidity have become one of the main challenges in health care worldwide. However, data on the burden of multimorbidity are still scarce. The purpose of this study is to examine the association between multimorbidity and the health care utilization and costs in the Swiss community-dwelling population, taking into account several sociodemographic factors.MethodsThe study population consists of 229'493 individuals aged 65 or older who were insured in 2013 by the Helsana Group, the leading health insurer in Switzerland, covering all 26 Swiss cantons. Multimorbidity was defined as the presence of two or more chronic conditions of a list of 22 conditions that were identified using an updated measure of the Pharmacy-based Cost Group model. The number of consultations (total and divided by primary care physicians and specialists), the number of different physicians contacted, the type of physician contact (face-to-face, phone, and home visits), the number of hospitalisations and the length of stay were assessed separately for the multimorbid and non-multimorbid sample. The costs (total and divided by inpatient and outpatient costs) covered by the compulsory health insurance were calculated for both samples. Multiple linear regression modelling was conducted to adjust for influencing factors: age, sex, linguistic region, purchasing power, insurance plan, and nursing dependency.ResultsPrevalence of multimorbidity was 76.6%. The mean number of consultations per year was 15.7 in the multimorbid compared to 4.4 in the non-multimorbid sample. Total costs were 5.5 times higher in multimorbid patients. Each additional chronic condition was associated with an increase of 3.2 consultations and increased costs of 33%. Strong positive associations with utilization and costs were also found for nursing dependency. Multimorbid patients were 5.6 times more likely to be hospitalised. Furthermore, results revealed a significant age-gender interaction and a socioeconomic gradient.ConclusionsMultimorbidity is associated with substantial higher health care utilization and costs in Switzerland. Quantified data on the current burden of multimorbidity are fundamental for the management of patients in health service delivery systems and for health care policy debates about resource allocation. Strategies for a better coordination of multimorbid patients are urgently needed.Electronic supplementary materialThe online version of this article (doi:10.1186/s12913-015-0698-2) contains supplementary material, which is available to authorized users.

Multimorbidity and Health-Related Quality of Life among Older Adults

“…Older adults with multimorbidity who are more likely to experience loss of physical functioning, develop mental health related issues and have difficulties with adherence to multiple medications [7] are the main users of healthcare. It is estimated that medical consultations are almost 4-fold and healthcare costs are 5.5 times higher among older adults with multimorbidity when compared to those without multimorbidity [8].…”

Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies

“…Thus, the burden to society is expected to increase substantially, at least for hip or knee replacement surgery (10). In addition, OA prevalence could result in increased cardiovascular morbidity as an indirect consequence of reduced physical activity and increased need for nursing home facilities for the elderly population (11).…”

Pitkäaikaissairaudet ja monisairastavuus hyvin vanhoilla sekä niiden yhteys toimintakykyyn ja itse arvioituun terveyteen – Tervaskannot 90+ -tutkimus

“…Monisairastavuus on yleistä iäkkäillä, erityisesti naisilla (Bähler, Huber, Brüngger & Reich 2015;Barnett ym. 2012;Marengoni ym.…”